nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—Vinblastine—head and neck cancer	0.136	0.343	CbGbCtD
Methylprednisolone—ABCB1—Docetaxel—head and neck cancer	0.112	0.282	CbGbCtD
Methylprednisolone—CYP3A4—Vinblastine—head and neck cancer	0.0815	0.205	CbGbCtD
Methylprednisolone—CYP3A4—Docetaxel—head and neck cancer	0.0671	0.169	CbGbCtD
Methylprednisolone—Erythema facial—Hydroxyurea—head and neck cancer	0.0398	0.0666	CcSEcCtD
Methylprednisolone—Skin atrophy—Hydroxyurea—head and neck cancer	0.0241	0.0403	CcSEcCtD
Methylprednisolone—Atrophy—Hydroxyurea—head and neck cancer	0.0223	0.0373	CcSEcCtD
Methylprednisolone—Telangiectasia—Fluorouracil—head and neck cancer	0.0222	0.0372	CcSEcCtD
Methylprednisolone—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.0122	0.0205	CcSEcCtD
Methylprednisolone—Peptic ulcer—Vinblastine—head and neck cancer	0.0119	0.02	CcSEcCtD
Methylprednisolone—Neuritis—Vinblastine—head and neck cancer	0.0107	0.0179	CcSEcCtD
Methylprednisolone—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00879	0.0147	CcSEcCtD
Methylprednisolone—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00827	0.0138	CcSEcCtD
Methylprednisolone—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00694	0.0116	CcSEcCtD
Methylprednisolone—Menstruation irregular—Docetaxel—head and neck cancer	0.00682	0.0114	CcSEcCtD
Methylprednisolone—Necrosis—Fluorouracil—head and neck cancer	0.00666	0.0112	CcSEcCtD
Methylprednisolone—Tingling sensation—Fluorouracil—head and neck cancer	0.00651	0.0109	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00647	0.0108	CcSEcCtD
Methylprednisolone—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00635	0.0106	CcSEcCtD
Methylprednisolone—Embolism—Docetaxel—head and neck cancer	0.00588	0.00985	CcSEcCtD
Methylprednisolone—Leukocytosis—Fluorouracil—head and neck cancer	0.00557	0.00932	CcSEcCtD
Methylprednisolone—Inflammation—Fluorouracil—head and neck cancer	0.00539	0.00903	CcSEcCtD
Methylprednisolone—Neuritis—Docetaxel—head and neck cancer	0.00506	0.00847	CcSEcCtD
Methylprednisolone—Necrosis—Docetaxel—head and neck cancer	0.00481	0.00805	CcSEcCtD
Methylprednisolone—Oesophagitis—Fluorouracil—head and neck cancer	0.00478	0.008	CcSEcCtD
Methylprednisolone—Breast disorder—Hydroxyurea—head and neck cancer	0.00477	0.00798	CcSEcCtD
Methylprednisolone—Euphoric mood—Fluorouracil—head and neck cancer	0.00449	0.00753	CcSEcCtD
Methylprednisolone—Pancreatitis—Hydroxyurea—head and neck cancer	0.00447	0.00748	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00439	0.00736	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00439	0.00734	CcSEcCtD
Methylprednisolone—Myocardial infarction—Vinblastine—head and neck cancer	0.00437	0.00732	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00437	0.00732	CcSEcCtD
Methylprednisolone—Amenorrhoea—Docetaxel—head and neck cancer	0.0043	0.00719	CcSEcCtD
Methylprednisolone—Weight increased—Hydroxyurea—head and neck cancer	0.00415	0.00695	CcSEcCtD
Methylprednisolone—Infestation NOS—Hydroxyurea—head and neck cancer	0.00407	0.00681	CcSEcCtD
Methylprednisolone—Infestation—Hydroxyurea—head and neck cancer	0.00407	0.00681	CcSEcCtD
Methylprednisolone—Amnesia—Fluorouracil—head and neck cancer	0.00404	0.00677	CcSEcCtD
Methylprednisolone—Haemoglobin—Vinblastine—head and neck cancer	0.00402	0.00673	CcSEcCtD
Methylprednisolone—Haemorrhage—Vinblastine—head and neck cancer	0.004	0.0067	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00398	0.00667	CcSEcCtD
Methylprednisolone—Inflammation—Docetaxel—head and neck cancer	0.00389	0.00652	CcSEcCtD
Methylprednisolone—Cardiac failure—Fluorouracil—head and neck cancer	0.00389	0.00651	CcSEcCtD
Methylprednisolone—Osteoarthritis—Fluorouracil—head and neck cancer	0.0038	0.00636	CcSEcCtD
Methylprednisolone—Haemoglobin—Hydroxyurea—head and neck cancer	0.00367	0.00614	CcSEcCtD
Methylprednisolone—Haemorrhage—Hydroxyurea—head and neck cancer	0.00365	0.00611	CcSEcCtD
Methylprednisolone—Hallucination—Hydroxyurea—head and neck cancer	0.00363	0.00608	CcSEcCtD
Methylprednisolone—Irritability—Fluorouracil—head and neck cancer	0.00362	0.00607	CcSEcCtD
Methylprednisolone—Cardiac arrest—Fluorouracil—head and neck cancer	0.00361	0.00605	CcSEcCtD
Methylprednisolone—Skin exfoliation—Docetaxel—head and neck cancer	0.0036	0.00604	CcSEcCtD
Methylprednisolone—Fluid retention—Docetaxel—head and neck cancer	0.00358	0.006	CcSEcCtD
Methylprednisolone—Neuropathy—Docetaxel—head and neck cancer	0.00354	0.00594	CcSEcCtD
Methylprednisolone—Oesophagitis—Docetaxel—head and neck cancer	0.00345	0.00578	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Docetaxel—head and neck cancer	0.00336	0.00563	CcSEcCtD
Methylprednisolone—Muscular weakness—Fluorouracil—head and neck cancer	0.00335	0.00561	CcSEcCtD
Methylprednisolone—Angiopathy—Hydroxyurea—head and neck cancer	0.00331	0.00554	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Vinblastine—head and neck cancer	0.00323	0.00541	CcSEcCtD
Methylprednisolone—Erythema—Hydroxyurea—head and neck cancer	0.00318	0.00532	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Docetaxel—head and neck cancer	0.00317	0.0053	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00315	0.00528	CcSEcCtD
Methylprednisolone—Malaise—Vinblastine—head and neck cancer	0.00314	0.00526	CcSEcCtD
Methylprednisolone—Vertigo—Vinblastine—head and neck cancer	0.00313	0.00524	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00302	0.00506	CcSEcCtD
Methylprednisolone—Convulsion—Vinblastine—head and neck cancer	0.00302	0.00505	CcSEcCtD
Methylprednisolone—Hypertension—Vinblastine—head and neck cancer	0.00301	0.00504	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00295	0.00494	CcSEcCtD
Methylprednisolone—Discomfort—Vinblastine—head and neck cancer	0.00293	0.00491	CcSEcCtD
Methylprednisolone—Infestation NOS—Fluorouracil—head and neck cancer	0.00293	0.0049	CcSEcCtD
Methylprednisolone—Infestation—Fluorouracil—head and neck cancer	0.00293	0.0049	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00288	0.00483	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00287	0.0048	CcSEcCtD
Methylprednisolone—Myocardial infarction—Fluorouracil—head and neck cancer	0.00287	0.0048	CcSEcCtD
Methylprednisolone—Malaise—Hydroxyurea—head and neck cancer	0.00286	0.0048	CcSEcCtD
Methylprednisolone—Cardiac failure—Docetaxel—head and neck cancer	0.00281	0.0047	CcSEcCtD
Methylprednisolone—Convulsion—Hydroxyurea—head and neck cancer	0.00275	0.00461	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00269	0.0045	CcSEcCtD
Methylprednisolone—Discomfort—Hydroxyurea—head and neck cancer	0.00267	0.00447	CcSEcCtD
Methylprednisolone—Haemoglobin—Fluorouracil—head and neck cancer	0.00264	0.00442	CcSEcCtD
Methylprednisolone—Rhinitis—Fluorouracil—head and neck cancer	0.00263	0.00441	CcSEcCtD
Methylprednisolone—Haemorrhage—Fluorouracil—head and neck cancer	0.00263	0.0044	CcSEcCtD
Methylprednisolone—Infection—Hydroxyurea—head and neck cancer	0.00258	0.00431	CcSEcCtD
Methylprednisolone—Paraesthesia—Vinblastine—head and neck cancer	0.00255	0.00427	CcSEcCtD
Methylprednisolone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00254	0.00426	CcSEcCtD
Methylprednisolone—Skin disorder—Hydroxyurea—head and neck cancer	0.00252	0.00422	CcSEcCtD
Methylprednisolone—Breast disorder—Docetaxel—head and neck cancer	0.00248	0.00415	CcSEcCtD
Methylprednisolone—Clobetasol propionate—CYP1A1—head and neck cancer	0.00242	0.4	CrCbGaD
Methylprednisolone—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00242	0.00405	CcSEcCtD
Methylprednisolone—Arrhythmia—Fluorouracil—head and neck cancer	0.00235	0.00393	CcSEcCtD
Methylprednisolone—Feeling abnormal—Vinblastine—head and neck cancer	0.00234	0.00392	CcSEcCtD
Methylprednisolone—Bronchospasm—Docetaxel—head and neck cancer	0.00233	0.0039	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00232	0.00389	CcSEcCtD
Methylprednisolone—Erythema—Fluorouracil—head and neck cancer	0.00229	0.00383	CcSEcCtD
Methylprednisolone—Dyspepsia—Hydroxyurea—head and neck cancer	0.00228	0.00382	CcSEcCtD
Methylprednisolone—Abdominal pain—Vinblastine—head and neck cancer	0.00225	0.00376	CcSEcCtD
Methylprednisolone—Fatigue—Hydroxyurea—head and neck cancer	0.00224	0.00374	CcSEcCtD
Methylprednisolone—Weight increased—Docetaxel—head and neck cancer	0.00216	0.00361	CcSEcCtD
Methylprednisolone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00214	0.00358	CcSEcCtD
Methylprednisolone—Infestation NOS—Docetaxel—head and neck cancer	0.00211	0.00354	CcSEcCtD
Methylprednisolone—Infestation—Docetaxel—head and neck cancer	0.00211	0.00354	CcSEcCtD
Methylprednisolone—Hypersensitivity—Vinblastine—head and neck cancer	0.00209	0.00351	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00208	0.00349	CcSEcCtD
Methylprednisolone—Myocardial infarction—Docetaxel—head and neck cancer	0.00207	0.00347	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00207	0.00347	CcSEcCtD
Methylprednisolone—Asthenia—Vinblastine—head and neck cancer	0.00204	0.00342	CcSEcCtD
Methylprednisolone—Convulsion—Fluorouracil—head and neck cancer	0.00198	0.00332	CcSEcCtD
Methylprednisolone—Myalgia—Fluorouracil—head and neck cancer	0.00195	0.00326	CcSEcCtD
Methylprednisolone—Diarrhoea—Vinblastine—head and neck cancer	0.00195	0.00326	CcSEcCtD
Methylprednisolone—Discomfort—Fluorouracil—head and neck cancer	0.00192	0.00322	CcSEcCtD
Methylprednisolone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00191	0.0032	CcSEcCtD
Methylprednisolone—Haemoglobin—Docetaxel—head and neck cancer	0.00191	0.00319	CcSEcCtD
Methylprednisolone—Rhinitis—Docetaxel—head and neck cancer	0.0019	0.00318	CcSEcCtD
Methylprednisolone—Haemorrhage—Docetaxel—head and neck cancer	0.0019	0.00317	CcSEcCtD
Methylprednisolone—Confusional state—Fluorouracil—head and neck cancer	0.00188	0.00315	CcSEcCtD
Methylprednisolone—Dizziness—Vinblastine—head and neck cancer	0.00188	0.00315	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00187	0.00312	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Docetaxel—head and neck cancer	0.00186	0.00312	CcSEcCtD
Methylprednisolone—Asthenia—Hydroxyurea—head and neck cancer	0.00186	0.00311	CcSEcCtD
Methylprednisolone—Infection—Fluorouracil—head and neck cancer	0.00185	0.0031	CcSEcCtD
Methylprednisolone—Nervous system disorder—Fluorouracil—head and neck cancer	0.00183	0.00306	CcSEcCtD
Methylprednisolone—Visual impairment—Docetaxel—head and neck cancer	0.00183	0.00306	CcSEcCtD
Methylprednisolone—Tachycardia—Fluorouracil—head and neck cancer	0.00182	0.00305	CcSEcCtD
Methylprednisolone—Vomiting—Vinblastine—head and neck cancer	0.00181	0.00303	CcSEcCtD
Methylprednisolone—Headache—Vinblastine—head and neck cancer	0.00178	0.00298	CcSEcCtD
Methylprednisolone—Diarrhoea—Hydroxyurea—head and neck cancer	0.00177	0.00297	CcSEcCtD
Methylprednisolone—Eye disorder—Docetaxel—head and neck cancer	0.00177	0.00297	CcSEcCtD
Methylprednisolone—Cardiac disorder—Docetaxel—head and neck cancer	0.00176	0.00295	CcSEcCtD
Methylprednisolone—Hypotension—Fluorouracil—head and neck cancer	0.00174	0.00292	CcSEcCtD
Methylprednisolone—Angiopathy—Docetaxel—head and neck cancer	0.00172	0.00288	CcSEcCtD
Methylprednisolone—Dizziness—Hydroxyurea—head and neck cancer	0.00171	0.00287	CcSEcCtD
Methylprednisolone—Immune system disorder—Docetaxel—head and neck cancer	0.00171	0.00287	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Docetaxel—head and neck cancer	0.00171	0.00286	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0017	0.00285	CcSEcCtD
Methylprednisolone—Arrhythmia—Docetaxel—head and neck cancer	0.00169	0.00284	CcSEcCtD
Methylprednisolone—Nausea—Vinblastine—head and neck cancer	0.00169	0.00283	CcSEcCtD
Methylprednisolone—Insomnia—Fluorouracil—head and neck cancer	0.00169	0.00283	CcSEcCtD
Methylprednisolone—Paraesthesia—Fluorouracil—head and neck cancer	0.00168	0.00281	CcSEcCtD
Methylprednisolone—Mental disorder—Docetaxel—head and neck cancer	0.00166	0.00278	CcSEcCtD
Methylprednisolone—Malnutrition—Docetaxel—head and neck cancer	0.00165	0.00276	CcSEcCtD
Methylprednisolone—Erythema—Docetaxel—head and neck cancer	0.00165	0.00276	CcSEcCtD
Methylprednisolone—Vomiting—Hydroxyurea—head and neck cancer	0.00165	0.00276	CcSEcCtD
Methylprednisolone—Dyspepsia—Fluorouracil—head and neck cancer	0.00164	0.00275	CcSEcCtD
Methylprednisolone—Rash—Hydroxyurea—head and neck cancer	0.00163	0.00274	CcSEcCtD
Methylprednisolone—Dermatitis—Hydroxyurea—head and neck cancer	0.00163	0.00273	CcSEcCtD
Methylprednisolone—Headache—Hydroxyurea—head and neck cancer	0.00162	0.00272	CcSEcCtD
Methylprednisolone—Nausea—Hydroxyurea—head and neck cancer	0.00154	0.00258	CcSEcCtD
Methylprednisolone—Feeling abnormal—Fluorouracil—head and neck cancer	0.00154	0.00258	CcSEcCtD
Methylprednisolone—Urticaria—Fluorouracil—head and neck cancer	0.00148	0.00248	CcSEcCtD
Methylprednisolone—Syncope—Docetaxel—head and neck cancer	0.00148	0.00248	CcSEcCtD
Methylprednisolone—Loss of consciousness—Docetaxel—head and neck cancer	0.00145	0.00243	CcSEcCtD
Methylprednisolone—Convulsion—Docetaxel—head and neck cancer	0.00143	0.00239	CcSEcCtD
Methylprednisolone—Hypertension—Docetaxel—head and neck cancer	0.00142	0.00239	CcSEcCtD
Methylprednisolone—Arthralgia—Docetaxel—head and neck cancer	0.00141	0.00235	CcSEcCtD
Methylprednisolone—Myalgia—Docetaxel—head and neck cancer	0.00141	0.00235	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.0014	0.00234	CcSEcCtD
Methylprednisolone—Hypersensitivity—Fluorouracil—head and neck cancer	0.00138	0.0023	CcSEcCtD
Methylprednisolone—Confusional state—Docetaxel—head and neck cancer	0.00136	0.00227	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Docetaxel—head and neck cancer	0.00135	0.00226	CcSEcCtD
Methylprednisolone—Infection—Docetaxel—head and neck cancer	0.00134	0.00224	CcSEcCtD
Methylprednisolone—Shock—Docetaxel—head and neck cancer	0.00133	0.00222	CcSEcCtD
Methylprednisolone—Nervous system disorder—Docetaxel—head and neck cancer	0.00132	0.00221	CcSEcCtD
Methylprednisolone—Pruritus—Fluorouracil—head and neck cancer	0.00132	0.00221	CcSEcCtD
Methylprednisolone—Tachycardia—Docetaxel—head and neck cancer	0.00131	0.0022	CcSEcCtD
Methylprednisolone—Skin disorder—Docetaxel—head and neck cancer	0.00131	0.00219	CcSEcCtD
Methylprednisolone—Diarrhoea—Fluorouracil—head and neck cancer	0.00128	0.00214	CcSEcCtD
Methylprednisolone—Hypotension—Docetaxel—head and neck cancer	0.00126	0.00211	CcSEcCtD
Methylprednisolone—Dizziness—Fluorouracil—head and neck cancer	0.00123	0.00207	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00123	0.00205	CcSEcCtD
Methylprednisolone—Insomnia—Docetaxel—head and neck cancer	0.00122	0.00204	CcSEcCtD
Methylprednisolone—Paraesthesia—Docetaxel—head and neck cancer	0.00121	0.00203	CcSEcCtD
Methylprednisolone—Triamcinolone—PTGS2—head and neck cancer	0.00119	0.196	CrCbGaD
Methylprednisolone—Vomiting—Fluorouracil—head and neck cancer	0.00119	0.00199	CcSEcCtD
Methylprednisolone—Dyspepsia—Docetaxel—head and neck cancer	0.00119	0.00199	CcSEcCtD
Methylprednisolone—Rash—Fluorouracil—head and neck cancer	0.00118	0.00197	CcSEcCtD
Methylprednisolone—Dermatitis—Fluorouracil—head and neck cancer	0.00118	0.00197	CcSEcCtD
Methylprednisolone—Headache—Fluorouracil—head and neck cancer	0.00117	0.00196	CcSEcCtD
Methylprednisolone—Fatigue—Docetaxel—head and neck cancer	0.00116	0.00194	CcSEcCtD
Methylprednisolone—Feeling abnormal—Docetaxel—head and neck cancer	0.00111	0.00186	CcSEcCtD
Methylprednisolone—Nausea—Fluorouracil—head and neck cancer	0.00111	0.00186	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.0011	0.00184	CcSEcCtD
Methylprednisolone—Abdominal pain—Docetaxel—head and neck cancer	0.00106	0.00178	CcSEcCtD
Methylprednisolone—Hypersensitivity—Docetaxel—head and neck cancer	0.000992	0.00166	CcSEcCtD
Methylprednisolone—Betamethasone—PTGS2—head and neck cancer	0.000974	0.161	CrCbGaD
Methylprednisolone—Asthenia—Docetaxel—head and neck cancer	0.000966	0.00162	CcSEcCtD
Methylprednisolone—Pruritus—Docetaxel—head and neck cancer	0.000953	0.0016	CcSEcCtD
Methylprednisolone—Diarrhoea—Docetaxel—head and neck cancer	0.000922	0.00154	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP1A1—head and neck cancer	0.000906	0.15	CrCbGaD
Methylprednisolone—Dizziness—Docetaxel—head and neck cancer	0.000891	0.00149	CcSEcCtD
Methylprednisolone—Vomiting—Docetaxel—head and neck cancer	0.000856	0.00143	CcSEcCtD
Methylprednisolone—Rash—Docetaxel—head and neck cancer	0.000849	0.00142	CcSEcCtD
Methylprednisolone—Dermatitis—Docetaxel—head and neck cancer	0.000849	0.00142	CcSEcCtD
Methylprednisolone—Headache—Docetaxel—head and neck cancer	0.000844	0.00141	CcSEcCtD
Methylprednisolone—Nausea—Docetaxel—head and neck cancer	0.0008	0.00134	CcSEcCtD
Methylprednisolone—Dexamethasone—PTGS2—head and neck cancer	0.000566	0.0935	CrCbGaD
